375 related articles for article (PubMed ID: 12876202)
1. Profiling receptor tyrosine kinase activation by using Ab microarrays.
Nielsen UB; Cardone MH; Sinskey AJ; MacBeath G; Sorger PK
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9330-5. PubMed ID: 12876202
[TBL] [Abstract][Full Text] [Related]
2. Microbead arrays for the analysis of ErbB receptor tyrosine kinase activation and dimerization in breast cancer cells.
Khan IH; Zhao J; Ghosh P; Ziman M; Sweeney C; Kung HJ; Luciw PA
Assay Drug Dev Technol; 2010 Feb; 8(1):27-36. PubMed ID: 20035613
[TBL] [Abstract][Full Text] [Related]
3. BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at different concentrations in intact cells.
Egeblad M; Mortensen OH; van Kempen LC; Jäättelä M
Biochem Biophys Res Commun; 2001 Feb; 281(1):25-31. PubMed ID: 11178955
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
5. Analysis of changes in phosphorylation of receptor tyrosine kinases: antibody arrays.
Rani S; O'Driscoll L
Methods Mol Biol; 2015; 1233():15-23. PubMed ID: 25319885
[TBL] [Abstract][Full Text] [Related]
6. Contact spotting of protein microarrays coupled with spike-in of normalizer protein permits time-resolved analysis of ERBB receptor signaling.
Löbke C; Laible M; Rappl C; Ruschhaupt M; Sahin O; Arlt D; Wiemann S; Poustka A; Sültmann H; Korf U
Proteomics; 2008 Apr; 8(8):1586-94. PubMed ID: 18351692
[TBL] [Abstract][Full Text] [Related]
7. Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays.
Gujral TS; Karp RL; Finski A; Chan M; Schwartz PE; MacBeath G; Sorger P
Oncogene; 2013 Jul; 32(29):3470-6. PubMed ID: 22945653
[TBL] [Abstract][Full Text] [Related]
8. Distinct mechanisms of receptor and nonreceptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metalloprotease and protein kinase C-delta.
Frank GD; Mifune M; Inagami T; Ohba M; Sasaki T; Higashiyama S; Dempsey PJ; Eguchi S
Mol Cell Biol; 2003 Mar; 23(5):1581-9. PubMed ID: 12588978
[TBL] [Abstract][Full Text] [Related]
9. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling.
Graus-Porta D; Beerli RR; Hynes NE
Mol Cell Biol; 1995 Mar; 15(3):1182-91. PubMed ID: 7532277
[TBL] [Abstract][Full Text] [Related]
10. Peptide microarrays for profiling of serine/threonine kinase activity of recombinant kinases and lysates of cells and tissue samples.
Hilhorst R; Houkes L; Mommersteeg M; Musch J; van den Berg A; Ruijtenbeek R
Methods Mol Biol; 2013; 977():259-71. PubMed ID: 23436369
[TBL] [Abstract][Full Text] [Related]
11. Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins.
Teutschbein J; Haydn JM; Samans B; Krause M; Eilers M; Schartl M; Meierjohann S
BMC Cancer; 2010 Jul; 10():386. PubMed ID: 20663135
[TBL] [Abstract][Full Text] [Related]
12. Feedback inhibition by RALT controls signal output by the ErbB network.
Anastasi S; Fiorentino L; Fiorini M; Fraioli R; Sala G; Castellani L; Alemà S; Alimandi M; Segatto O
Oncogene; 2003 Jul; 22(27):4221-34. PubMed ID: 12833145
[TBL] [Abstract][Full Text] [Related]
13. Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction.
Murakami Y; Fukazawa H; Mizuno S; Uehara Y
Biol Pharm Bull; 1998 Oct; 21(10):1030-5. PubMed ID: 9821805
[TBL] [Abstract][Full Text] [Related]
14. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B
Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
Frohnert PW; Stonecypher MS; Carroll SL
Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
[TBL] [Abstract][Full Text] [Related]
16. Array-based proteomic approaches to study signal transduction pathways: prospects, merits and challenges.
Gahoi N; Ray S; Srivastava S
Proteomics; 2015 Jan; 15(2-3):218-31. PubMed ID: 25266292
[TBL] [Abstract][Full Text] [Related]
17. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
18. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner.
Bos M; Mendelsohn J; Kim YM; Albanell J; Fry DW; Baselga J
Clin Cancer Res; 1997 Nov; 3(11):2099-106. PubMed ID: 9815602
[TBL] [Abstract][Full Text] [Related]
19. Activation-dependent clustering of the erbB2 receptor tyrosine kinase detected by scanning near-field optical microscopy.
Nagy P; Jenei A; Kirsch AK; Szöllosi J; Damjanovich S; Jovin TM
J Cell Sci; 1999 Jun; 112 ( Pt 11)():1733-41. PubMed ID: 10318765
[TBL] [Abstract][Full Text] [Related]
20. Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
Voshol H; Ehrat M; Traenkle J; Bertrand E; van Oostrum J
FEBS J; 2009 Dec; 276(23):6871-9. PubMed ID: 19860827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
